Rapid Infuser Market Segmentation, Analysis by Recent Trends, Development & Growth by Regions by 2032

BySanket Badgujar
MicrosoftTeams-image-064d998e

The global Rapid Infuser Market is set to enjoy a valuation of US$ 1.01 Bn in 2022, and further expand at a CAGR of 4.6% to reach US$ 1.52 Bn by the year 2031. According to a recent study by Future Market Insights, reusable devices are leading the market by usability with a share of 74.2% in 2021 within the global market. The market value for rapid infuser holds around 19% of the overall global intravenous infusion pump market which accounts for approximately US$ 5 Bn in 2021.

In a new report, Future Market Insights has provided comprehensive details on essential business strategies that find roles in the rapid infusers market. Market leaders in the industry have been emphasizing on the expansion of their portfolios with efforts on product research. Also, strategic acquisitions are gaining ground in the industry.

Get Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6716

Rapid Infusers Market Key Takeaways

  • Market revenues will surpass USD 817 million, with anaesthesia, and emergency healthcare applications being the primary driving factors
  • Hospitals will remain the leading end users, while ASCs are also likely to reflect steady growth on the back of growing adoption in outpatient medical procedures.
  • Trolley mounted offerings continue to witness market preference, owing to portability and ease of use in hospital settings, accounting for ~70% of market share.
  • North America followed by Europe, are leading regional markets for rapid infusers, supported by the massive investments into the healthcare sector, and easier access to new hospital and emergency care technologies.

“The global market for rapid infusers is driven by growing number of surgical procedures and high risk of hypothermia and hypovolemia. This product is also widely considered an important intervention in life-threatening ailments such as sepsis. These issues are major influencers in terms of market development through the forecast period,” said a lead analyst from FMI.

Rapid Infusers Market – Who is Winning?

Smith’s Medical, GE Healthcare, BD, 3M Company, Stryker Corporation, ZOLL Medical Corporation, Belmont Instrument, Smisson-Cartledge Biomedical, Kewell Medical Technology Co. Ltd, Teleflex Incorporated, Biegler GmbHALC “TahatAksi”

Covid-19 Impact on Rapid Infusers Market

The COVID-19 pandemic is expected to marginally impact the rapid infusers market. Demand largely remains stable as rapid infusers are standard equipment in most healthcare facilities for critical care applications. The demand for reusable rapid infusers is likely to fall in favor of single-use alternatives, owing to concerns over viral transmission.

Potential disruptions of raw material and component supplies due to lockdown and trade restrictions are concerns. However, the essential natures of the products, makes the industry largely exempt from government restrictions. Demand is unlikely to change substantially even in the post-pandemic period as applications in urology, gynecology, and ICUs continue unabated.

Key Market Segments Covered in Rapid Infuser Industry Research

By Product:

  • Trolley Mounted Devices
  • Hand-Held Devices
  • Accessories

By Usability:

  • Single-Use Devices
  • Reusable Devices

By End-User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Speciality Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

More Insights

The Future Market Insights report has given readers a detailed analysis of the global rapid infusers market, with critical information on historical demand and for forecast statistics (2022 – 2031). The report also encompasses a detailed analysis in terms of costs, pricing, and other major dynamic factors that influence tech developments and production decisions for rapid infusers in varied healthcare applications.

 

0